Page 147 - Annual report 2021-22
P. 147
Annual Report 2021-22 |
GAP0215 DEVELOPMENT OF AN AL PLATFORM FOR HUMAN HEALTH
INHALABLE GAPMER TARGETING TOLL-LIKE RECEPTORS (TLR7/8) TO CALM THE CYTOKINE STORM IN
GAP0234
COVID19
GAP0248 GIISER SOUTH ASIA
130
GAP0249 MICROLABS BASED GENOMIC SURVEILLANCE OF THE SARS-COV-2
FLOOR MICROBIOME ANALYSIS USING SHOTGUN METAGENOMICS TO ELUCIDATE MICROBIAL
CLP0030 ASSEMBLAGES ON DIFFERENT FLOOR SURFACES OF HOUSES OF TWO SOCIO-ECONOMIC CATEGORIES
FROM DELHI, INDIA
REAL TIME HIGH-THROUGHPUT COST-EFFECTIVE SEQUENCING PLATFORM FOR 2019-N-COV
CLP0033
DETECTION AND GENOTYPING
CLP0036 COVID-19: ENHANCE GENOMIC SURVEILLANCE &; GENETIC EPIDEMIOLOGY OF SARS COV 2 IN INDIA
CLP0043 MICRO LABS BASED SARS-COV-2 GENOMIC SURVEILLANCE FOR VACCINE BREAKTHROUGH IN INDIA
OLP1147 DIFFERENTIAL DIAGNOSIS OF SILICOSIS AND TB IN SIROHI, RAJASTHAN
OLP1149 GENOME BASED CHARACTERIZATION OF P. ACNES AND STRATEGIES TO CONTROL ACNE DISEASE
SARS-COV2 VIRAL PSEUDOTYPING AND SYNCYTIA FORMATION ASSAYS AS SURROGATES OF
OLP1157
INFECTIVITY, IMMUNE EVASION AND PATHOGENESIS
OLP1158 MOLECULAR INVESTIGATIONS OF RISING MUCORMYCOSIS AND OTHER FUNGAL INFECTIONS IN INDIA
